๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ten-year results of a randomized trial on adjuvant chemo-endocrine therapy with tamoxifen for stage II breast cancer

โœ Scribed by Yoshinobu Hata; Hiromasa Takahashi; Satoru Todo; Minoru Okazaki; Kazuaki Asaishi; Koichi Hirata; Shunichi Okushiba; Hiroyuki Kato; Junichi Uchino

Publisher
Springer Japan
Year
2003
Tongue
English
Weight
478 KB
Volume
10
Category
Article
ISSN
1340-6868

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Twelve-year mortality results of a rando
Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01)
โœ Maurizio Belfiglio; Miriam Valentini; Fabio Pellegrini; Giorgia De Berardis; Mon ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND This study evaluated the impact on overall survival (OS) of 2 versus 5 years adjuvant tamoxifen in early breast carcinoma patients after 12 years of followโ€up. ## METHODS Women with breast carcinoma T1โ€“3, N0โ€“3, M0, aged 50โ€“70 years, were eligible for this multicenter ra

Randomized adjuvant trial to evaluate th
Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5-year results from the nishi-nippon group of the adjuvant chemoendocrine therapy for breast cancer organization
โœ Masakazu Toil; Takao Hattori; Masanobu Akagi; Kiyoshi Lnokuchi; Kunzo Orita; Kei ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 714 KB

Background. A randomized adjuvant trial was conducted from October 1982 to January 1985 to evaluate the addition of tamoxifen (TAM) to combination chemotherapy with perioperative mitomycin C (MMC) and ftorafur (FT) for patients with estrogen receptor (ER)-positive tumors and the addition of PSK, a b

A randomized trial of long term adjuvant
A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery
โœ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 101 KB ๐Ÿ‘ 2 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w